SMMT logo

Summit Therapeutics Inc. (SMMT) Cash and cash equivalents

annual cash & cash equivalents:

$412.67M+$226.43M(+121.58%)
December 31, 2024

Summary

  • As of today (August 31, 2025), SMMT annual cash & cash equivalents is $412.67 million, with the most recent change of +$226.43 million (+121.58%) on December 31, 2024.
  • During the last 3 years, SMMT annual cash & cash equivalents has risen by +$340.88 million (+474.83%).
  • SMMT annual cash & cash equivalents is now -36.38% below its all-time high of $648.61 million, reached on December 31, 2022.

Performance

SMMT Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTbalance sheet metrics

quarterly cash & cash equivalents:

$298.19M-$63.44M(-17.54%)
June 30, 2025

Summary

  • As of today (August 31, 2025), SMMT quarterly cash & cash equivalents is $298.19 million, with the most recent change of -$63.44 million (-17.54%) on June 30, 2025.
  • Over the past year, SMMT quarterly cash & cash equivalents has dropped by -$27.60 million (-8.47%).
  • SMMT quarterly cash & cash equivalents is now -54.03% below its all-time high of $648.61 million, reached on December 31, 2022.

Performance

SMMT quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

SMMT Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+121.6%-8.5%
3 y3 years+474.8%+420.1%
5 y5 years+543.4%-

SMMT Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-36.4%+474.8%-54.0%+420.1%
5 y5-year-36.4%+543.4%-54.0%+1301.9%
alltimeall time-36.4%>+9999.0%-54.0%>+9999.0%

SMMT Cash and cash equivalents History

DateAnnualQuarterly
Jun 2025
-
$298.19M(-17.5%)
Mar 2025
-
$361.63M(-12.4%)
Dec 2024
$412.67M(+121.6%)
$412.67M(-15.3%)
Sep 2024
-
$487.22M(+49.6%)
Jun 2024
-
$325.79M(+107.5%)
Mar 2024
-
$157.00M(-15.7%)
Dec 2023
$186.24M(-71.3%)
$186.24M(-6.4%)
Sep 2023
-
$198.94M(-7.5%)
Jun 2023
-
$215.01M(-11.1%)
Mar 2023
-
$241.93M(-62.7%)
Dec 2022
$648.61M(+803.5%)
$648.61M(+431.8%)
Sep 2022
-
$121.97M(+112.7%)
Jun 2022
-
$57.34M(-26.0%)
Mar 2022
-
$77.45M(+7.9%)
Dec 2021
$71.79M(+8.1%)
$71.79M(-10.5%)
Sep 2021
-
$80.25M(-22.4%)
Jun 2021
-
$103.39M(+1.2%)
Mar 2021
-
$102.19M(+53.9%)
Dec 2020
$66.42M(+3.5%)
-
Dec 2020
-
$66.42M(+212.3%)
Sep 2020
-
$21.27M(-61.4%)
Mar 2020
-
$55.05M(+55.8%)
Dec 2019
$64.14M(+124.4%)
-
Jan 2019
-
$35.33M(+112.0%)
Oct 2018
-
$16.67M(-25.8%)
Jul 2018
-
$22.47M(-39.3%)
Apr 2018
-
$36.99M(+29.4%)
Jan 2018
$28.59M(-19.0%)
-
Jan 2018
-
$28.59M(-32.3%)
Oct 2017
-
$42.24M(+13.3%)
Jul 2017
-
$37.30M(+48.9%)
Apr 2017
-
$25.05M(-29.0%)
Jan 2017
$35.30M(+52.7%)
-
Jan 2017
-
$35.30M(-16.5%)
Oct 2016
-
$42.28M(+355.2%)
Jul 2016
-
$9.29M(-36.5%)
Apr 2016
-
$14.63M(-36.7%)
Jan 2016
$23.13M
-
DateAnnualQuarterly
Jan 2016
-
$23.13M(-32.5%)
Oct 2015
-
$34.27M(-16.9%)
Jul 2015
-
$41.25M(-8.7%)
Apr 2015
-
$45.20M(+167.2%)
Jan 2015
$16.92M(+407.1%)
-
Jan 2015
-
$16.92M(-29.5%)
Oct 2014
-
$24.01M(-18.6%)
Jul 2014
-
$29.49M(+780.7%)
Jan 2014
$3.34M(-37.7%)
-
Jan 2014
-
$3.35M(-63.4%)
Jul 2013
-
$9.15M(+71.4%)
Jan 2013
$5.36M(+63.5%)
-
Jan 2013
-
$5.34M(-28.5%)
Jul 2012
-
$7.47M(+129.1%)
Jan 2012
$3.28M(-37.1%)
-
Jan 2012
-
$3.26M(-46.1%)
Jul 2011
-
$6.04M(+17.5%)
Jan 2011
$5.21M(-46.6%)
-
Jan 2011
-
$5.14M(-27.9%)
Jul 2010
-
$7.13M(-26.6%)
Jan 2010
$9.75M(+148.8%)
-
Jan 2010
-
$9.72M(+575.5%)
Jul 2009
-
$1.44M(-63.3%)
Jan 2009
$3.92M(-80.5%)
-
Jan 2009
-
$3.92M(-75.3%)
Jul 2008
-
$15.86M(-21.0%)
Jan 2008
$20.05M(-44.0%)
-
Jan 2008
-
$20.06M(-30.6%)
Jul 2007
-
$28.91M(-19.4%)
Jan 2007
$35.80M(+59.4%)
-
Jan 2007
-
$35.87M(-5.0%)
Jul 2006
-
$37.77M(+1934.2%)
Jan 2006
$22.45M(-15.9%)
-
Jan 2006
-
$1.86M(-91.8%)
Jul 2005
-
$22.67M(-15.0%)
Jan 2005
$26.71M(>+9900.0%)
-
Jan 2005
-
$26.66M(>+9900.0%)
Jul 2004
-
$176.70K
Jan 2004
$144.90K
-

FAQ

  • What is Summit Therapeutics Inc. annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. annual cash & cash equivalents year-on-year change?
  • What is Summit Therapeutics Inc. quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. quarterly cash & cash equivalents year-on-year change?

What is Summit Therapeutics Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of SMMT is $412.67M

What is the all time high annual cash & cash equivalents for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high annual cash & cash equivalents is $648.61M

What is Summit Therapeutics Inc. annual cash & cash equivalents year-on-year change?

Over the past year, SMMT annual cash & cash equivalents has changed by +$226.43M (+121.58%)

What is Summit Therapeutics Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of SMMT is $298.19M

What is the all time high quarterly cash & cash equivalents for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high quarterly cash & cash equivalents is $648.61M

What is Summit Therapeutics Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, SMMT quarterly cash & cash equivalents has changed by -$27.60M (-8.47%)
On this page